
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4AE5A8AF308F305AE5A004E185EB3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367135/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system">
<meta name="citation_author" content="Yun Kim">
<meta name="citation_author_institution" content="College of Pharmacy, Daegu Catholic University, Gyeongsan, Republic of Korea">
<meta name="citation_author" content="Yeabin Yook">
<meta name="citation_author_institution" content="Department of Pharmacy, Wonkwang University College of Pharmacy, Iksan, Republic of Korea">
<meta name="citation_author" content="Su-jin Rhee">
<meta name="citation_author_institution" content="Department of Pharmacy, Wonkwang University College of Pharmacy, Iksan, Republic of Korea">
<meta name="citation_author_institution" content="Institute of Pharmaceutical Research, Wonkwang University College of Pharmacy, Iksan, Republic of Korea">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0330493">
<meta name="citation_doi" content="10.1371/journal.pone.0330493">
<meta name="citation_pmid" content="40833961">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367135/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367135/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367135/pdf/pone.0330493.pdf">
<meta name="description" content="Tinnitus, a distressing condition that can significantly impair quality of life, has been associated with several medications, including triptans. This study aimed to explore the relationship between tinnitus and specific migraine treatments, ...">
<meta name="og:title" content="Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Tinnitus, a distressing condition that can significantly impair quality of life, has been associated with several medications, including triptans. This study aimed to explore the relationship between tinnitus and specific migraine treatments, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367135/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12367135">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0330493"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0330493.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367135%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12367135/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12367135/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367135/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0330493" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 20;20(8):e0330493. doi: <a href="https://doi.org/10.1371/journal.pone.0330493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330493</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yun Kim</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yun Kim</span></h3>
<div class="p">
<sup>1</sup>College of Pharmacy, Daegu Catholic University, Gyeongsan, Republic of Korea</div>
<div>Conceptualization, Investigation, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yun Kim</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yook%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yeabin Yook</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yeabin Yook</span></h3>
<div class="p">
<sup>2</sup>Department of Pharmacy, Wonkwang University College of Pharmacy, Iksan, Republic of Korea</div>
<div>Data curation, Formal analysis, Visualization, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yook%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yeabin Yook</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rhee%20SJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Su-jin Rhee</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Su-jin Rhee</span></h3>
<div class="p">
<sup>2</sup>Department of Pharmacy, Wonkwang University College of Pharmacy, Iksan, Republic of Korea</div>
<div class="p">
<sup>3</sup>Institute of Pharmaceutical Research, Wonkwang University College of Pharmacy, Iksan, Republic of Korea</div>
<div>Conceptualization, Formal analysis, Investigation, Supervision, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rhee%20SJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Su-jin Rhee</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Hantong Hu</span><sup>4</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>College of Pharmacy, Daegu Catholic University, Gyeongsan, Republic of Korea</div>
<div id="aff002">
<sup>2</sup>Department of Pharmacy, Wonkwang University College of Pharmacy, Iksan, Republic of Korea</div>
<div id="aff003">
<sup>3</sup>Institute of Pharmaceutical Research, Wonkwang University College of Pharmacy, Iksan, Republic of Korea</div>
<div id="edit1">
<sup>4</sup>The Affiliated Hospital of Zhejiang Chinese Medical University, CHINA</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>rheesj05@wku.ac.kr</span></p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Yun Kim</span></strong>: <span class="role">Conceptualization, Investigation, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Yeabin Yook</span></strong>: <span class="role">Data curation, Formal analysis, Visualization, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Su-jin Rhee</span></strong>: <span class="role">Conceptualization, Formal analysis, Investigation, Supervision, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Hantong Hu</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jun 9; Accepted 2025 Aug 2; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Kim et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12367135  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40833961/" class="usa-link">40833961</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Tinnitus, a distressing condition that can significantly impair quality of life, has been associated with several medications, including triptans. This study aimed to explore the relationship between tinnitus and specific migraine treatments, focusing on triptans and calcitonin gene-related peptide (CGRP) inhibitors. Data from the FDA Adverse Event Reporting System (FAERS) through the third quarter of 2023 were analyzed to calculate proportional reporting ratios (PRR) and reporting odds ratios (ROR) for migraine treatments, specifically triptans and CGRP inhibitors. Positive tinnitus signals were identified when PRRs or RORs were greater than 2.0, the lower bound of the 95% confidence interval exceeded 1.0, and at least three cases were reported. Intra- and inter-class analyses were conducted to compare tinnitus reports among individual drugs and drug classes. Among 47,615 tinnitus-related adverse events, 345 were associated with CGRP inhibitors and 183 with triptans. Positive tinnitus signals were observed for several CGRP inhibitors, except eptinezumab and atogepant, and for all triptans except sumatriptan. Inter-class analysis revealed no significant differences between triptans and CGRP inhibitors. However, intra-class analysis identified naratriptan, almotriptan, and frovatriptan as having notable tinnitus signals among triptans, while CGRP inhibitors did not exhibit strong signals for any specific drug. Using real-world data from FAERS and pharmacovigilance methods, this study identified tinnitus signals related to migraine treatments, particularly among certain triptans. These findings provide preliminary evidence for further investigation into the relationship between migraine medications and tinnitus.</p></section><section id="sec001"><h2 class="pmc_sec_title">Introduction</h2>
<p>Tinnitus, often described as the perception of sound in the absence of any external auditory stimulus, is a prevalent and distressing condition affecting millions of individuals worldwide [<a href="#pone.0330493.ref001" class="usa-link" aria-describedby="pone.0330493.ref001">1</a>–<a href="#pone.0330493.ref003" class="usa-link" aria-describedby="pone.0330493.ref003">3</a>]. From a faint ringing to a persistent buzzing or roaring, tinnitus manifests in various forms and intensities, profoundly impacting the daily lives of those affected. Tinnitus is bothersome and persistent, sometimes lasting for 6 months or longer, and it often negatively impacts patient’s quality of life. While most patients are less severely affected, some may experience anxiety, depression, and extreme life changes [<a href="#pone.0330493.ref004" class="usa-link" aria-describedby="pone.0330493.ref004">4</a>]. Despite its prevalence, the underlying mechanisms of tinnitus remain complex and multifaceted, posing significant challenges for effective management and treatment [<a href="#pone.0330493.ref001" class="usa-link" aria-describedby="pone.0330493.ref001">1</a>,<a href="#pone.0330493.ref005" class="usa-link" aria-describedby="pone.0330493.ref005">5</a>]. To date, no medications have been specifically approved to treat tinnitus by the US Food and Drug Administration (FDA) [<a href="#pone.0330493.ref006" class="usa-link" aria-describedby="pone.0330493.ref006">6</a>,<a href="#pone.0330493.ref007" class="usa-link" aria-describedby="pone.0330493.ref007">7</a>].</p>
<p>While the exact causes of tinnitus are not fully understood, it has been associated with factors such as exposure to loud noise, hearing loss, blockage of the ear canal by earwax or by fluid from an ear infection, head or neck injuries damaging structures of the ear. Tinnitus can also be a side effect of taking certain medications, especially if they are taken at high doses. Medications associated with tinnitus include non-steroidal anti-inflammatory drugs (e.g., ibuprofen, naproxen, and aspirin), certain antibiotics, anti-cancer drugs, and anti-malaria medications [<a href="#pone.0330493.ref008" class="usa-link" aria-describedby="pone.0330493.ref008">8</a>,<a href="#pone.0330493.ref009" class="usa-link" aria-describedby="pone.0330493.ref009">9</a>]. Triptans, a class of drugs commonly prescribed for the relief of migraine headaches, have also been occasionally associated with reports of tinnitus onset or exacerbation [<a href="#pone.0330493.ref010" class="usa-link" aria-describedby="pone.0330493.ref010">10</a>–<a href="#pone.0330493.ref013" class="usa-link" aria-describedby="pone.0330493.ref013">13</a>]. While the precise mechanisms underlying this potential association are not fully understood, the recognition of such adverse event reports highlights the need to investigate the relationship between migraine treatments and tinnitus.</p>
<p>Various therapies are available for the treatment and prevention of migraines, including onabotulinumtoxinA, beta-blockers like propranolol and timolol, and anticonvulsants such as topiramate, divalproex sodium, valproate sodium, and valproic acid. Additionally, serotonin receptor agonists, including triptans (5-HT<sub>1B/1D</sub>) and lasmiditan (5-HT<sub>1F</sub>), as well as the nonsteroidal anti-inflammatory drug (NSAID) celecoxib, have received approval for acute or episodic migraine treatment. Current clinical guidelines often recommend triptans as a prior treatment option [<a href="#pone.0330493.ref014" class="usa-link" aria-describedby="pone.0330493.ref014">14</a>]. Furthermore, the landscape of migraine therapeutics has evolved in recent years with the emergence of calcitonin gene-related peptide (CGRP) inhibitors. These novel medications represent a promising avenue for migraine management, offering new possibilities for patients who have experienced limited relief or intolerable side effects with existing treatments [<a href="#pone.0330493.ref015" class="usa-link" aria-describedby="pone.0330493.ref015">15</a>]. Nevertheless, like with any novel class of drugs, it is crucial to conduct a comprehensive evaluation of their safety profile, including the potential risk of adverse events. For instance, while the occurrence of tinnitus as an adverse reaction hasn’t been documented in the Food and Drug Administration (FDA) labeling of CGRP inhibitors thus far, a prior study analyzing disproportionality signals through the FDA’s voluntary adverse event reporting system (FAERS) identified tinnitus as a notable signal for erenumab [<a href="#pone.0330493.ref016" class="usa-link" aria-describedby="pone.0330493.ref016">16</a>].</p>
<p>The FAERS is a pivotal resource for post-marketing safety surveillance of approved drugs, enabling the accumulation and management of adverse event reports submitted voluntarily by consumers, pharmaceutical companies, healthcare professionals, and others involved in drug usage. FAERS compiles adverse events and medication errors reported to the FDA, and presents them in a user-friendly and interactive format through its public dashboard. The accessibility and comprehensiveness of FAERS data have spurred a surge in research endeavors aimed at evaluating the potential for adverse reactions associated with medications and uncovering novel adverse event insights previously undisclosed, thereby driving advancements in pharmacovigilance and drug safety [<a href="#pone.0330493.ref017" class="usa-link" aria-describedby="pone.0330493.ref017">17</a>,<a href="#pone.0330493.ref018" class="usa-link" aria-describedby="pone.0330493.ref018">18</a>].</p>
<p>Against this background, our study seeks to explore the intricate interplay between tinnitus and specific migraine treatments, with a particular focus on triptans and CGRP inhibitors. Utilizing the vast dataset accessible via the FAERS database, we aim to elucidate patterns of tinnitus occurrence associated with these medications. Our investigation aims not only to quantify tinnitus prevalence in patients receiving these treatments but also to compare different and within-class drugs to evaluate risk and better understand potential causes of tinnitus associated with their use.</p></section><section id="sec002"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec003"><h3 class="pmc_sec_title">Data source</h3>
<p>The FAERS adverse event reports from the first quarter of 1968 through the third quarter of 2023 were extracted, with a focus on serotonin receptor agonists (e.g., triptans and lasmiditan) and CGRP inhibitors. Additionally, FDA-approved migraine treatments, including onabotulinumtoxinA, beta-blockers (e.g., propranolol and timolol), anticonvulsants (e.g., topiramate and valproates), and celecoxib, were also included in the analysis. Nonproprietary medication names were utilized to evaluate individual medications; combination products were excluded to ensure clarity and precision. Tinnitus cases were identified using the Medical Dictionary for Regulatory Activities preferred term “tinnitus” [<a href="#pone.0330493.ref019" class="usa-link" aria-describedby="pone.0330493.ref019">19</a>]. Only adverse events reported under this specific preferred term were included to ensure methodological consistency [<a href="#pone.0330493.ref020" class="usa-link" aria-describedby="pone.0330493.ref020">20</a>]. The data used in this study were accessed in November 2023 from the publicly available FDA website. As this study used publicly available, anonymized data from the FAERS, no identifiable personal information was accessed. Therefore, institutional review board approval and informed consent were not required.</p></section><section id="sec004"><h3 class="pmc_sec_title">Disproportionality analysis</h3>
<p>The association between tinnitus and migraine treatments was assessed using a case/non-case approach. Tinnitus events reported for a suspect drug were considered cases, while other events were considered non-cases. Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) were calculated to measure disproportionality, comparing tinnitus cases associated with each medication to those reported with all other drugs. PRR and ROR calculations were conducted using Microsoft Excel 2019. The PRR formula evaluated the ratio of reports for tinnitus with the medication of interest to all other medications, while the ROR compared the odds of reporting tinnitus with the medication to all other medications [<a href="#pone.0330493.ref018" class="usa-link" aria-describedby="pone.0330493.ref018">18</a>,<a href="#pone.0330493.ref021" class="usa-link" aria-describedby="pone.0330493.ref021">21</a>]. Additional analyses were performed focusing on specific subgroups of tinnitus reports restricted to migraine prophylaxis, migraine, or headache as a reason for use.</p>
<p>Significant signal indicators were determined based on predefined thresholds, with a PRR or ROR &gt; 2.0 and the lower limit of a 95% confidence interval &gt;1.0 considered positive signals. Additionally, signals required a minimum of three reported cases to ensure reliability [<a href="#pone.0330493.ref022" class="usa-link" aria-describedby="pone.0330493.ref022">22</a>,<a href="#pone.0330493.ref023" class="usa-link" aria-describedby="pone.0330493.ref023">23</a>]. Any identified signals were thoroughly investigated for clinical relevance and patient safety implications. Additionally, the FDA labels of each medication were scrutinized to determine if tinnitus had been reported as an adverse reaction. This step aimed to offer comprehensive insight into potential associations between tinnitus and the specified migraine treatments, and to assess the consistency of the analysis results with existing drug characteristic information.</p></section><section id="sec005"><h3 class="pmc_sec_title">Intra- and inter-class analysis</h3>
<p>To comprehensively understand tinnitus reporting patterns among migraine medications, both intra-class and inter-class investigations were conducted. Intra-class analyses were performed within each of the serotonin receptor agonist and CGRP inhibitor classes to delve deeper into the association of individual drugs within each class with tinnitus. Additionally, for inter-class analysis, each migraine drug treatment class was compared to either triptans or CGRP inhibitors as references, respectively, using PRR and ROR calculations. This approach was intended to account for potential confounding factors and provide insights into the relative tinnitus reporting among different classes of migraine treatments.</p></section></section><section id="sec006"><h2 class="pmc_sec_title">Results</h2>
<section id="sec007"><h3 class="pmc_sec_title">Data description</h3>
<p>A total of 81,147 adverse events were reported for CGRP inhibitors, and 44,105 adverse events were reported for serotonin receptor agonists (<a href="#pone.0330493.t001" class="usa-link">Table 1</a>). Among the 47,615 adverse events related to tinnitus, 345 were associated with CGRP inhibitors, and 187 were associated with serotonin receptor agonists (183 with triptans and 4 with lasmiditan). For most drugs, the incidence rate of tinnitus compared to the total number of events was less than 1%, ranging from 0.3% to 0.6% for CGRP inhibitors, and 0.3% to 3.2% for serotonin receptor agonists. However, certain triptans, such as frovatriptan, naratriptan, and almotriptan, showed higher incidence rates ranging from 1.9% to 3.2%.</p>
<section class="tw xbox font-sm" id="pone.0330493.t001"><h4 class="obj_head">Table 1. Descriptive statistics for adverse events and tinnitus cases for each migraine drug reported in FAERS database.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" colspan="2" rowspan="2">Pharmacologic class</th>
<th align="left" rowspan="2" colspan="1">Drug name</th>
<th align="left" colspan="2" rowspan="1">Indication unrestricted<sup>a</sup>
</th>
<th align="left" rowspan="2" colspan="1">PRR (95% CI)</th>
<th align="left" rowspan="2" colspan="1">ROR (95% CI)</th>
<th align="left" colspan="2" rowspan="1">Indication restricted<sup>a</sup>
</th>
<th align="left" rowspan="2" colspan="1">PRR (95% CI)</th>
<th align="left" rowspan="2" colspan="1">ROR (95% CI)</th>
<th align="left" rowspan="2" colspan="1">Tinnitus on drug label</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Total events</th>
<th align="left" rowspan="1" colspan="1">Tinnitus cases</th>
<th align="left" rowspan="1" colspan="1">Total events</th>
<th align="left" rowspan="1" colspan="1">Tinnitus cases</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="7" colspan="1">CGRP inhibitors</td>
<td align="left" rowspan="3" colspan="1">CGRP antagonists</td>
<td align="left" rowspan="1" colspan="1">Fremanezumab<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">5835</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">3.51 (2.54–4.87)</td>
<td align="left" rowspan="1" colspan="1">3.53 (2.54–4.90)</td>
<td align="left" rowspan="1" colspan="1">2660</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">5.99 (4.15–8.66)</td>
<td align="left" rowspan="1" colspan="1">6.05 (4.17-8.78)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Galcanezumab<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">20390</td>
<td align="left" rowspan="1" colspan="1">78</td>
<td align="left" rowspan="1" colspan="1">2.18 (1.75–2.72)</td>
<td align="left" rowspan="1" colspan="1">2.18 (1.75–2.73)</td>
<td align="left" rowspan="1" colspan="1">10216</td>
<td align="left" rowspan="1" colspan="1">56</td>
<td align="left" rowspan="1" colspan="1">3.12 (2.40–4.05)</td>
<td align="left" rowspan="1" colspan="1">3.13 (2.41-4.08)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Eptinezumab</td>
<td align="left" rowspan="1" colspan="1">2862</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">1.19 (0.54–2.65)</td>
<td align="left" rowspan="1" colspan="1">1.19 (0.54–2.66)</td>
<td align="left" rowspan="1" colspan="1">2190</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.04 (0.39–2.77)</td>
<td align="left" rowspan="1" colspan="1">1.04 (0.39-2.77)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="4" colspan="1">CGRP receptor antagonists</td>
<td align="left" rowspan="1" colspan="1">Erenumab<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">41117</td>
<td align="left" rowspan="1" colspan="1">187</td>
<td align="left" rowspan="1" colspan="1">2.59 (2.25–2.99)</td>
<td align="left" rowspan="1" colspan="1">2.60 (2.25–3.00)</td>
<td align="left" rowspan="1" colspan="1">25341</td>
<td align="left" rowspan="1" colspan="1">136</td>
<td align="left" rowspan="1" colspan="1">3.06 (2.59–3.62)</td>
<td align="left" rowspan="1" colspan="1">3.07 (2.59-3.64)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rimegepant</td>
<td align="left" rowspan="1" colspan="1">6493</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">1.93 (1.27–2.93)</td>
<td align="left" rowspan="1" colspan="1">1.93 (1.27–2.94)</td>
<td align="left" rowspan="1" colspan="1">3634</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">2.66 (1.66–4.28)</td>
<td align="left" rowspan="1" colspan="1">2.67 (1.66-4.30)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ubrogepant<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">1663</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">2.74 (1.37–5.47)</td>
<td align="left" rowspan="1" colspan="1">2.75 (1.37–5.50)</td>
<td align="left" rowspan="1" colspan="1">1024</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">2.78 (1.16–6.66)</td>
<td align="left" rowspan="1" colspan="1">2.79 (1.16-6.71)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Atogepant</td>
<td align="left" rowspan="1" colspan="1">2787</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">1.63 (0.82–3.26)</td>
<td align="left" rowspan="1" colspan="1">1.64 (0.82–3.27)</td>
<td align="left" rowspan="1" colspan="1">1115</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2.04 (0.77–5.43)</td>
<td align="left" rowspan="1" colspan="1">2.05 (0.77-5.46)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="8" colspan="1">Serotonin receptor agonists</td>
<td align="left" rowspan="7" colspan="1">Triptans</td>
<td align="left" rowspan="1" colspan="1">Sumatriptan</td>
<td align="left" rowspan="1" colspan="1">30573</td>
<td align="left" rowspan="1" colspan="1">78</td>
<td align="left" rowspan="1" colspan="1">1.45 (1.16–1.81)</td>
<td align="left" rowspan="1" colspan="1">1.45 (1.16–1.82)</td>
<td align="left" rowspan="1" colspan="1">16867</td>
<td align="left" rowspan="1" colspan="1">61</td>
<td align="left" rowspan="1" colspan="1">2.06 (1.60–2.65)</td>
<td align="left" rowspan="1" colspan="1">2.06 (1.60-2.65)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zolmitriptan<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">3402</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">3.35 (2.16–5.18)</td>
<td align="left" rowspan="1" colspan="1">3.36 (2.16–5.22)</td>
<td align="left" rowspan="1" colspan="1">2089</td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">5.18 (3.31–8.10)</td>
<td align="left" rowspan="1" colspan="1">5.22 (3.32-8.19)</td>
<td align="left" rowspan="1" colspan="1">Y</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rizatriptan<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">3252</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">4.38 (2.96–6.47)</td>
<td align="left" rowspan="1" colspan="1">4.40 (2.97–6.53)</td>
<td align="left" rowspan="1" colspan="1">2282</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">4.99 (3.22–7.72)</td>
<td align="left" rowspan="1" colspan="1">5.02 (3.23-7.8)</td>
<td align="left" rowspan="1" colspan="1">Y</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Naratriptan<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">991</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">11.49 (7.44–17.73)</td>
<td align="left" rowspan="1" colspan="1">11.71 (7.52–18.23)</td>
<td align="left" rowspan="1" colspan="1">759</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">15.00 (9.73–23.12)</td>
<td align="left" rowspan="1" colspan="1">15.38 (9.86-23.98)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Almotriptan<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">574</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">10.91 (6.07–19.59)</td>
<td align="left" rowspan="1" colspan="1">11.10 (6.11–20.16)</td>
<td align="left" rowspan="1" colspan="1">428</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">14.63 (8.16–26.22)</td>
<td align="left" rowspan="1" colspan="1">14.99 (8.24-27.28)</td>
<td align="left" rowspan="1" colspan="1">Y</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Frovatriptan<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">436</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">18.28 (10.92–30.6)</td>
<td align="left" rowspan="1" colspan="1">18.85 (11.07–32.11)</td>
<td align="left" rowspan="1" colspan="1">367</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">21.71 (12.99–36.3)</td>
<td align="left" rowspan="1" colspan="1">22.54 (13.21-38.45)</td>
<td align="left" rowspan="1" colspan="1">Y</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Eletriptan<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">4042</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">2.11 (1.27–3.50)</td>
<td align="left" rowspan="1" colspan="1">2.12 (1.27–3.51)</td>
<td align="left" rowspan="1" colspan="1">2729</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">2.71 (1.58–4.66)</td>
<td align="left" rowspan="1" colspan="1">2.72 (1.58-4.69)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ditan</td>
<td align="left" rowspan="1" colspan="1">Lasmiditan<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">835</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2.73 (1.03–7.25)</td>
<td align="left" rowspan="1" colspan="1">2.73 (1.02–7.30)</td>
<td align="left" rowspan="1" colspan="1">445</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">5.12 (1.93–13.57)</td>
<td align="left" rowspan="1" colspan="1">5.15 (1.93-13.79)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">Acetylcholine release inhibitor</td>
<td align="left" rowspan="1" colspan="1">OnabotulinumtoxinA</td>
<td align="left" rowspan="1" colspan="1">56687</td>
<td align="left" rowspan="1" colspan="1">194</td>
<td align="left" rowspan="1" colspan="1">1.95 (1.70-2.25)</td>
<td align="left" rowspan="1" colspan="1">1.95 (1.70–2.25)</td>
<td align="left" rowspan="1" colspan="1">6575</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">3.46 (2.54–4.72)</td>
<td align="left" rowspan="1" colspan="1">3.48 (2.55–4.75)</td>
<td align="left" rowspan="1" colspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="2">Beta-blockers</td>
<td align="left" rowspan="1" colspan="1">Propranolol<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">23914</td>
<td align="left" rowspan="1" colspan="1">199</td>
<td align="left" rowspan="1" colspan="1">4.75 (4.14-5.46)</td>
<td align="left" rowspan="1" colspan="1">4.78 (4.16–5.50)</td>
<td align="left" rowspan="1" colspan="1">2064</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td align="left" rowspan="1" colspan="1">8.28 (5.80–11.81)</td>
<td align="left" rowspan="1" colspan="1">8.38 (5.85–12.02)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Timolol</td>
<td align="left" rowspan="1" colspan="1">13047</td>
<td align="left" rowspan="1" colspan="1">79</td>
<td align="left" rowspan="1" colspan="1">3.45 (2.77-4.30)</td>
<td align="left" rowspan="1" colspan="1">3.46 (2.78–4.32)</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">–</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="2">Anticonvulsants</td>
<td align="left" rowspan="1" colspan="1">Topiramate<sup>c</sup>
</td>
<td align="left" rowspan="1" colspan="1">34630</td>
<td align="left" rowspan="1" colspan="1">193</td>
<td align="left" rowspan="1" colspan="1">3.18 (2.76-3.66)</td>
<td align="left" rowspan="1" colspan="1">3.19 (2.77–3.68)</td>
<td align="left" rowspan="1" colspan="1">8934</td>
<td align="left" rowspan="1" colspan="1">113</td>
<td align="left" rowspan="1" colspan="1">7.21 (6.00–8.66)</td>
<td align="left" rowspan="1" colspan="1">7.29 (6.06–8.78)</td>
<td align="left" rowspan="1" colspan="1">N</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Valproates<sup>b</sup>
</td>
<td align="left" rowspan="1" colspan="1">80700</td>
<td align="left" rowspan="1" colspan="1">199</td>
<td align="left" rowspan="1" colspan="1">1.40 (1.22-1.61)</td>
<td align="left" rowspan="1" colspan="1">1.41 (1.22–1.62)</td>
<td align="left" rowspan="1" colspan="1">1377</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">4.13 (2.23–7.67)</td>
<td align="left" rowspan="1" colspan="1">4.16 (2.23–7.74)</td>
<td align="left" rowspan="1" colspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">NSAID</td>
<td align="left" rowspan="1" colspan="1">Celecoxib</td>
<td align="left" rowspan="1" colspan="1">68663</td>
<td align="left" rowspan="1" colspan="1">430</td>
<td align="left" rowspan="1" colspan="1">3.59 (3.26-3.94)</td>
<td align="left" rowspan="1" colspan="1">3.60 (3.28–3.96)</td>
<td align="left" rowspan="1" colspan="1">646</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">2.64 (0.85–8.17)</td>
<td align="left" rowspan="1" colspan="1">2.65 (0.85–8.24)</td>
<td align="left" rowspan="1" colspan="1">Y</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330493.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="t001fn001"><p>PRR, proportional reporting ratio; ROR, reporting odds ratio; CI, confidence interval; CGRP, calcitonin gene-related peptide; FAERS, United States Food and Drug Administration Adverse Event Reporting System; NA, not applicable.</p></div>
<div class="fn" id="t001fn002"><p><sup>a</sup>“Indication restricted” refers to cases where the medications were specifically prescribed for the treatment of migraine prophylaxis, migraine, or headache, while “indication unrestricted” includes cases where the medications were used for various indications, not limited to migraine or headache.</p></div>
<div class="fn" id="t001fn003"><p><sup>b</sup>Valproates include divalproex sodium, valproate sodium, and valproic acid.</p></div>
<div class="fn" id="t001fn004"><p><sup>c</sup>Drugs meeting significance criteria in both PRR and ROR regardless of indication restrictions. Significance is determined when there are at least 3 cases reported, the point estimate of PRR and ROR is 2 or higher, and the lower limit of the confidence interval of the point estimate is 1 or higher.</p></div>
</div></section><p>Among tinnitus cases, 46.7% of those associated with CGRP inhibitors and 69.4% of those associated with serotonin receptor agonists were classified as serious. Notably, fremanezumab and erenumab among CGRP inhibitors, and all triptan drugs except for zolmitriptan showed high rates (&gt;50%) of serious cases. The majority of tinnitus adverse events related to CGRP inhibitors and serotonin receptor agonists were reported in women (70.1% and 75.4%, respectively). The reported age range for tinnitus associated with CGRP inhibitors was 21–77 years, while for serotonin receptor agonists (triptans), it was 15–81 years.</p></section><section id="sec008"><h3 class="pmc_sec_title">Drug label and disproportionality signals</h3>
<p>None of the FDA drug labels for CGRP inhibitors mentioned tinnitus occurrences. However, for triptans, some drugs such as zolmitriptan, rizatriptan, almotriptan, and frovatriptan were suggested to have possible tinnitus side effects, while this possibility was not addressed for lasmiditan. Other migraine drugs such as onabotulinumtoxinA, valproates, and celecoxib acknowledged potential tinnitus risks in their labels. More than three cases of tinnitus were reported for all CGRP inhibitors and serotonin receptor agonists. Positive tinnitus signals were identified for specific CGRP inhibitors (i.e., fremanezumab, galcanezumab, erenumab, and ubrogepant) and all serotonin receptor agonists except for sumatriptan. This significant trend remained consistent even when analyzing cases restricted to migraine-related indications (<a href="#pone.0330493.t001" class="usa-link">Table 1</a>).</p></section><section id="sec009"><h3 class="pmc_sec_title">Intra- and inter-class comparison</h3>
<p>Individual drugs within the CGRP inhibitor class showed non-significant values for both PRR and ROR compared to other CGRP inhibitors (<a href="#pone.0330493.g001" class="usa-link">Fig 1</a>). Conversely, naratriptan, almotriptan, and frovatriptan within the serotonin receptor agonist class showed significantly higher likelihoods of developing tinnitus compared to other drugs in the class (<a href="#pone.0330493.g002" class="usa-link">Fig 2</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330493.g001"><h4 class="obj_head">Fig 1. Proportional reporting ratios (PRR) and reporting odds ratios (ROR), each accompanied by their 95% confidence intervals, contrast tinnitus cases associated with individual calcitonin gene-related peptide (CGRP) inhibitors (or the broader CGRP drug class) against other drugs in the same class.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367135_pone.0330493.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c07/12367135/df59083fde1b/pone.0330493.g001.jpg" loading="lazy" height="391" width="714" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330493.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CGRP antagonists include fremanezumab, galcanezumab, and eptinezumab. CGRP biologics include erenumab, fremanezumab, galcanezumab, and eptinezumab.</p></figcaption></figure><figure class="fig xbox font-sm" id="pone.0330493.g002"><h4 class="obj_head">Fig 2. Proportional reporting ratios (PRR) and reporting odds ratios (ROR), each accompanied by their 95% confidence intervals, contrast tinnitus cases associated with individual serotonin receptor agonists against other drugs in the same class.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367135_pone.0330493.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c07/12367135/01091b1cd3ef/pone.0330493.g002.jpg" loading="lazy" height="413" width="752" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330493.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>In the inter-class analysis, no significant signal differences were found between serotonin receptor agonists and CGRP inhibitors. However, beta-blockers (i.e., propranolol) and anticonvulsants (i.e., topiramate and valproates) showed higher likelihoods of causing tinnitus when compared to CGRP inhibitors or serotonin receptor agonists (<a href="#pone.0330493.g003" class="usa-link">Fig 3</a>). However, in the analysis that did not restrict indications, this trend disappeared in the case of anticonvulsants, and the significance of beta-blockers also decreased (<a href="#pone.0330493.s001" class="usa-link">S1 Fig</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330493.g003"><h4 class="obj_head">Fig 3. Inter-class analysis of migraine drugs with indications restricted to migraine prophylaxis, migraine, or headache.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367135_pone.0330493.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c07/12367135/ca82f4b2e15d/pone.0330493.g003.jpg" loading="lazy" height="660" width="788" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330493.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Proportional reporting ratios (PRR) and reporting odds ratios (ROR), along with their respective 95% confidence intervals, contrast tinnitus cases associated with each migraine drug class against (a) CGRP inhibitors and (b) serotonin receptor agonists. CGRP stands for calcitonin gene-related peptide.</p></figcaption></figure></section></section><section id="sec010"><h2 class="pmc_sec_title">Discussion</h2>
<p>This study investigated the occurrence of tinnitus as a potential adverse drug reaction among medications commonly used to treat migraine, utilizing real-world data from the FAERS. Through comprehensive comparisons and evaluations of individual drugs and drug classes, we identified medications associated with either a lower or higher risk of tinnitus being reported. Our findings provide preliminary insights into the safety profiles of triptans and CGRP inhibitors, and uncover potential adverse events not previously addressed in drug labels. This study is significant because no previous research has comprehensively compared the risk of tinnitus across various migraine treatments.</p>
<p>Tinnitus, a bothersome symptom with no established treatment due to its unclear etiology and pathology, poses significant disruptions to daily life. Previous studies have highlighted a significant relationship between tinnitus and headache, suggesting a possible shared pathophysiological basis. Specifically, findings indicate that headaches often precede tinnitus onset, hinting at a potential temporal relationship between the two conditions. However, the exact causality or sequence between headaches and tinnitus remains elusive [<a href="#pone.0330493.ref024" class="usa-link" aria-describedby="pone.0330493.ref024">24</a>–<a href="#pone.0330493.ref028" class="usa-link" aria-describedby="pone.0330493.ref028">28</a>]. Prior research has reported improvements in tinnitus symptoms through the regulation of migraine triggers [<a href="#pone.0330493.ref029" class="usa-link" aria-describedby="pone.0330493.ref029">29</a>]. Furthermore, one study found that the severity of tinnitus and headache coincided in nearly half of the participants; in other words, when head pain intensified, their tinnitus followed suit, and vice versa [<a href="#pone.0330493.ref024" class="usa-link" aria-describedby="pone.0330493.ref024">24</a>]. Considering these insights collectively, the significant signal of tinnitus observed across most migraine treatments in our study suggests two plausible interpretations: firstly, the possibility of tinnitus manifestation as an adverse drug reaction, and secondly, the potential association between migraine and tinnitus occurrence, given that migraine sufferers, who primarily utilized these medications, showed a higher incidence of tinnitus.</p>
<p>Despite the emergence of a significant tinnitus signal, variations exist among drugs within each class of migraine treatments regarding the risk of tinnitus occurrence. For instance, among triptan drugs, sumatriptan and eletriptan demonstrated a relatively low likelihood of tinnitus development in our study, with no mention of tinnitus adverse reactions on their labels. Conversely, frovatriptan, naratriptan, and almotriptan exhibited a heightened risk of tinnitus compared to other triptans. Interestingly, previous study comparing the efficacy and safety of triptan drugs revealed that frovatriptan and naratriptan displayed relatively lower efficacy and slower onset of action when compared to Sumatriptan 100 mg as the standard dose [<a href="#pone.0330493.ref030" class="usa-link" aria-describedby="pone.0330493.ref030">30</a>,<a href="#pone.0330493.ref031" class="usa-link" aria-describedby="pone.0330493.ref031">31</a>]. Conversely, eletriptan, rizatriptan, and zolmitriptan, which showed relatively low signal indicators for tinnitus in our study, were associated with notable therapeutic effects among triptans. Specifically, eletriptan and rizatriptan demonstrated the highest pain-free rates at 2 hours among oral triptans, with eletriptan also exhibiting the highest 24-hour sustained pain-free rate. Additionally, a hierarchy of treatment effects has been suggested with eletriptan, almotriptan, and zolmitriptan ranked in order [<a href="#pone.0330493.ref032" class="usa-link" aria-describedby="pone.0330493.ref032">32</a>]. One meta-analysis study indicated that all oral triptans were effective and well-tolerated, with rizatriptan, eletriptan, and almotriptan providing the highest likelihood of consistent treatment success [<a href="#pone.0330493.ref033" class="usa-link" aria-describedby="pone.0330493.ref033">33</a>]. This raises the possibility that tinnitus occurrence might be related to differences in the effectiveness of migraine treatments, rather than being solely an adverse drug reaction. However, the case of almotriptan presents a paradox, as it is recognized for its consistent treatment success and efficacy, yet shows a high incidence of tinnitus [<a href="#pone.0330493.ref032" class="usa-link" aria-describedby="pone.0330493.ref032">32</a>,<a href="#pone.0330493.ref033" class="usa-link" aria-describedby="pone.0330493.ref033">33</a>]. This suggests a multifaceted relationship between migraine and tinnitus, implying that factors beyond drug efficacy may influence the observed results.</p>
<p>In light of these aspects, despite the possibility that tinnitus may simply be a concomitant symptom of migraine, further research is needed to explore these complexities and determine whether certain medications (such as almotriptan, naratriptan, and frovatriptan, as highlighted in our study) pose a higher risk for tinnitus in migraine patients. In particular, prospective observational studies or randomized controlled trials that explicitly monitor tinnitus as an adverse event would be valuable to better understand potential causal relationships. To our knowledge, tinnitus has rarely been reported as a pre-specified safety outcome in randomized controlled trials of migraine treatments, which limits the ability to assess this risk based on clinical trial data alone. Additionally, preclinical studies evaluating auditory effects of migraine medications may help elucidate the biological mechanisms underlying the tinnitus signals observed in pharmacovigilance data.</p>
<p>Regarding CGRP inhibitors, there remains uncertainty about the possibility of tinnitus occurrence, and their drug labels do not list tinnitus as an adverse reaction. However, our study highlighted that some CGRP inhibitors, such as fremanezumab, galcanezumab, and erenumab, are more likely associated with tinnitus occurrence. This finding is consistent with a previous study which analyzed FAERS data and suggested a significant tinnitus signal with erenumab, while the study suggested a potential coexistence of migraine and tinnitus, rather than interpreting it solely as an adverse drug reaction [<a href="#pone.0330493.ref016" class="usa-link" aria-describedby="pone.0330493.ref016">16</a>]. Nevertheless, given the variability in tinnitus occurrence among CGRP inhibitors, careful selection of medications is recommended, especially in patients with pre-existing tinnitus.</p>
<p>For other medications such as propranolol, topiramate, and valproates, our analysis showed a higher risk of tinnitus when these drugs were used specifically for migraine treatment (i.e., with indication restriction), compared to analyses without indication restrictions. This disparity in results according to indication restrictions likely reflects the prevalence of tinnitus as a symptom among migraine patients. Nevertheless, propranolol and topiramate still showed significant PRR and ROR values even in analyses not limited to migraine, making it difficult to rule out the possibility that these drugs could cause tinnitus. Notably, propranolol had a higher tinnitus risk index compared to serotonin receptor agonists or CGRP inhibitors, regardless of indication restrictions. While some reports suggest propranolol may induce tinnitus by affecting conductive tissues and increasing its intensity [<a href="#pone.0330493.ref034" class="usa-link" aria-describedby="pone.0330493.ref034">34</a>], others indicate it may alleviate certain types of tinnitus symptoms [<a href="#pone.0330493.ref035" class="usa-link" aria-describedby="pone.0330493.ref035">35</a>]. Although propranolol’s label does not mention the possibility of tinnitus induction, our study underscores the need for further research to explore its potential association with tinnitus occurrence, particularly in migraine patients.</p>
<p>Our study utilized the FAERS database, an open data source reflecting real-world conditions. While FAERS data provides the advantage of real-world evidence, it is important to acknowledge its limitations. Due to the nature of unrefined data, inaccuracies or errors may be present [<a href="#pone.0330493.ref017" class="usa-link" aria-describedby="pone.0330493.ref017">17</a>]; however, we believe that the analysis of large-scale data may mitigate these issues to some extent. Additionally, spontaneous adverse event reporting can result in duplicated cases, and causality cannot be definitively established due to the lack of verification. For instance, reports in the FAERS database are not always reviewed by a physician or audiologist; they are collected from a variety of sources, including both patients and healthcare professionals. Specific details regarding the characteristics of tinnitus are generally unavailable in the FAERS database. These include whether cases were acute or chronic, transient or progressive, their severity, timing of onset relative to drug administration, or resolution after discontinuation. Moreover, information about the type of medical intervention used to manage tinnitus or other contributing factors is also not reported. Therefore, while this study identifies potential associations between migraine treatments and tinnitus, further research, particularly clinical and observational studies, is essential to clarify these relationships. Despite these limitations, FAERS remains a crucial resource for identifying safety signals and generating hypotheses for further investigation, as it provides valuable insights into drug safety, including potential adverse events not captured in clinical trials [<a href="#pone.0330493.ref018" class="usa-link" aria-describedby="pone.0330493.ref018">18</a>,<a href="#pone.0330493.ref021" class="usa-link" aria-describedby="pone.0330493.ref021">21</a>].</p></section><section id="sec011"><h2 class="pmc_sec_title">Conclusions</h2>
<p>This study highlights potential associations between migraine treatments and the occurrence of tinnitus, offering preliminary insights that could inform future research and clinical decision-making. While our findings suggest that certain medications may be linked to a higher risk of tinnitus, we acknowledge that the small number of adverse event reports and the complexity of analyzing both acute and preventive treatments limit the strength of our conclusions. Our study does not provide definitive clinical recommendations but identifies areas where further research is needed to validate these associations and explore their clinical relevance. Clinicians should interpret these findings with caution and consider them as a starting point for deeper investigations into the safety profiles of migraine treatments. Ultimately, a more robust understanding of these potential risks will require larger studies and further exploration of the relationships between migraine, its treatments, and tinnitus.</p></section><section id="sec012"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0330493.s001"><div class="caption p">
<span>S1 Fig. Inter-class analysis of migraine drugs without restriction for indication.</span><p>Proportional reporting ratios (PRR) and reporting odds ratios (ROR), along with their respective 95% confidence intervals, contrast tinnitus cases associated with each migraine drug class against (a) CGRP inhibitors and (b) serotonin receptor agonists. CGRP stands for calcitonin gene-related peptide.</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367135/bin/pone.0330493.s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0330493.s001.pdf</a><sup> (313.7KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This paper was supported by Wonkwang University in 2023.</p></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>All data analyzed in this study are publicly available from the US Food and Drug Administration’s Adverse Event Reporting System (FAERS). The full FAERS dataset can be accessed via the FDA’s official website: <a href="https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html</a>
</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) received no specific funding for this work.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0330493.ref001">
<span class="label">1.</span><cite>Tunkel DE, Bauer CA, Sun GH, Rosenfeld RM, Chandrasekhar SS, Cunningham ER Jr, et al. Clinical practice guideline: tinnitus. Otolaryngol Head Neck Surg. 2014;151(2 Suppl):S1–40. doi: 10.1177/0194599814545325

</cite> [<a href="https://doi.org/10.1177/0194599814545325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25273878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Otolaryngol%20Head%20Neck%20Surg&amp;title=Clinical%20practice%20guideline:%20tinnitus&amp;author=DE%20Tunkel&amp;author=CA%20Bauer&amp;author=GH%20Sun&amp;author=RM%20Rosenfeld&amp;author=SS%20Chandrasekhar&amp;volume=151&amp;publication_year=2014&amp;pmid=25273878&amp;doi=10.1177/0194599814545325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref002">
<span class="label">2.</span><cite>Henry JA, Dennis KC, Schechter MA. General review of tinnitus: prevalence, mechanisms, effects, and management. J Speech Lang Hear Res. 2005;48(5):1204–35. doi: 10.1044/1092-4388(2005/084

</cite> [<a href="https://doi.org/10.1044/1092-4388(2005/084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16411806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Speech%20Lang%20Hear%20Res&amp;title=General%20review%20of%20tinnitus:%20prevalence,%20mechanisms,%20effects,%20and%20management&amp;author=JA%20Henry&amp;author=KC%20Dennis&amp;author=MA%20Schechter&amp;volume=48&amp;issue=5&amp;publication_year=2005&amp;pages=1204-35&amp;pmid=16411806&amp;doi=10.1044/1092-4388(2005/084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref003">
<span class="label">3.</span><cite>Hoffman HJ, Reed GW.
Epidemiology of tinnitus. In: Snow JB, editor. Tinnitus: Theory and Management. Lewiston, NY: BC Decker; 2004. pp. 16–41.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Tinnitus:%20Theory%20and%20Management&amp;author=HJ%20Hoffman&amp;author=GW.%20Reed&amp;author=JB%20Snow&amp;publication_year=2004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref004">
<span class="label">4.</span><cite>Lewis JE, Stephens SD, McKenna L. Tinnitus and suicide. Clin Otolaryngol Allied Sci. 1994;19(1):50–4. doi: 10.1111/j.1365-2273.1994.tb01147.x

</cite> [<a href="https://doi.org/10.1111/j.1365-2273.1994.tb01147.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8174302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Otolaryngol%20Allied%20Sci&amp;title=Tinnitus%20and%20suicide&amp;author=JE%20Lewis&amp;author=SD%20Stephens&amp;author=L%20McKenna&amp;volume=19&amp;issue=1&amp;publication_year=1994&amp;pages=50-4&amp;pmid=8174302&amp;doi=10.1111/j.1365-2273.1994.tb01147.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref005">
<span class="label">5.</span><cite>Bauer CA. Tinnitus. N Engl J Med. 2018;378(13):1224–31.
</cite> [<a href="https://doi.org/10.1056/NEJMcp1506631" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29601255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Tinnitus&amp;author=CA%20Bauer&amp;volume=378&amp;issue=13&amp;publication_year=2018&amp;pages=1224-31&amp;pmid=29601255&amp;doi=10.1056/NEJMcp1506631&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref006">
<span class="label">6.</span><cite>Elgoyhen AB, Langguth B. Pharmacological approaches to the treatment of tinnitus. Drug Discov Today. 2010;15(7–8):300–5. doi: 10.1016/j.drudis.2009.11.003

</cite> [<a href="https://doi.org/10.1016/j.drudis.2009.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19931642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Discov%20Today&amp;title=Pharmacological%20approaches%20to%20the%20treatment%20of%20tinnitus&amp;author=AB%20Elgoyhen&amp;author=B%20Langguth&amp;volume=15&amp;publication_year=2010&amp;pages=300-5&amp;pmid=19931642&amp;doi=10.1016/j.drudis.2009.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref007">
<span class="label">7.</span><cite>Kim SH, Kim D, Lee J-M, Lee SK, Kang HJ, Yeo SG. Review of pharmacotherapy for tinnitus. Healthcare (Basel). 2021;9(6):779. doi: 10.3390/healthcare9060779

</cite> [<a href="https://doi.org/10.3390/healthcare9060779" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8235102/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34205776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Healthcare%20(Basel)&amp;title=Review%20of%20pharmacotherapy%20for%20tinnitus&amp;author=SH%20Kim&amp;author=D%20Kim&amp;author=J-M%20Lee&amp;author=SK%20Lee&amp;author=HJ%20Kang&amp;volume=9&amp;issue=6&amp;publication_year=2021&amp;pages=779&amp;pmid=34205776&amp;doi=10.3390/healthcare9060779&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref008">
<span class="label">8.</span><cite>NIH – National Institute on Deafness and Other Communication Disorders (NIDCD) [Internet]. Tinnitus [cited 2024 Apr 8]. Available from: <a href="https://www.nidcd.nih.gov/health/tinnitus" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.nidcd.nih.gov/health/tinnitus</a></cite>
</li>
<li id="pone.0330493.ref009">
<span class="label">9.</span><cite>Szczepek AJ.
Safety pharmacology and tinnitus. In: Hock FJ, Gralinski MR, Pugsley MK, editors. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Cham; Springer: 2022. [cited 2024 April 8]. Available from: doi: 10.1007/978-3-030-73317-9_74-1</cite> [<a href="https://doi.org/10.1007/978-3-030-73317-9_74-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Discovery%20and%20Evaluation:%20Safety%20and%20Pharmacokinetic%20Assays.%20Cham;%20Springer&amp;title=Safety%20pharmacology%20and%20tinnitus.&amp;author=AJ.%20Szczepek&amp;author=FJ%20Hock&amp;author=MR%20Gralinski&amp;author=MK%20Pugsley&amp;publication_year=2022&amp;doi=10.1007/978-3-030-73317-9_74-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref010">
<span class="label">10.</span><cite>Food and Drug Administration [Internet]. Amneal: Zomig (Zolmitriptan) package insert. 2018. [cited 2024 Apr 8]. Available from: <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020768s023,021231s014,021450s010lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020768s023,021231s014,021450s010lbl.pdf</a></cite>
</li>
<li id="pone.0330493.ref011">
<span class="label">11.</span><cite>Food and Drug Administration [Internet]. Organon LLC: Maxalt (Rizatriptan Benzoate) package insert [cited 2024 Apr 8]. Available from: <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf</a></cite>
</li>
<li id="pone.0330493.ref012">
<span class="label">12.</span><cite>Food and Drug Administration [Internet]. Janssen Pharms: Axert (Almotriptan Malate) package insert. 2017. [cited 2024 April 8]. Available from: <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021001s015lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021001s015lbl.pdf</a></cite>
</li>
<li id="pone.0330493.ref013">
<span class="label">13.</span><cite>Food and Drug Administration [Internet]. Endo Pharms: Frova (Frovatriptan Succinate) package insert. [cited 2024 Apr 8]. Available from: <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021006s022lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021006s022lbl.pdf</a></cite>
</li>
<li id="pone.0330493.ref014">
<span class="label">14.</span><cite>Ailani J, Burch RC, Robbins MS. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021–39.
</cite> [<a href="https://doi.org/10.1111/head.14153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34160823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Headache&amp;title=The%20American%20Headache%20Society%20Consensus%20Statement:%20Update%20on%20integrating%20new%20migraine%20treatments%20into%20clinical%20practice&amp;author=J%20Ailani&amp;author=RC%20Burch&amp;author=MS%20Robbins&amp;volume=61&amp;issue=7&amp;publication_year=2021&amp;pages=1021-39&amp;pmid=34160823&amp;doi=10.1111/head.14153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref015">
<span class="label">15.</span><cite>Yang C-P, Liang C-S, Chang C-M, Yang C-C, Shih P-H, Yau Y-C, et al. Comparison of new pharmacologic agents with triptans for treatment of migraine: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(10):e2128544. doi: 10.1001/jamanetworkopen.2021.28544

</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2021.28544" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8506232/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34633423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw%20Open&amp;title=Comparison%20of%20new%20pharmacologic%20agents%20with%20triptans%20for%20treatment%20of%20migraine:%20a%20systematic%20review%20and%20meta-analysis&amp;author=C-P%20Yang&amp;author=C-S%20Liang&amp;author=C-M%20Chang&amp;author=C-C%20Yang&amp;author=P-H%20Shih&amp;volume=4&amp;issue=10&amp;publication_year=2021&amp;pmid=34633423&amp;doi=10.1001/jamanetworkopen.2021.28544&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref016">
<span class="label">16.</span><cite>Sessa M, Andersen M. New insight on the safety of erenumab: an analysis of spontaneous reports of adverse events recorded in the US Food and Drug Administration adverse event reporting system database. BioDrugs. 2021;35(2):215–27. doi: 10.1007/s40259-021-00469-8

</cite> [<a href="https://doi.org/10.1007/s40259-021-00469-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33609278/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioDrugs&amp;title=New%20insight%20on%20the%20safety%20of%20erenumab:%20an%20analysis%20of%20spontaneous%20reports%20of%20adverse%20events%20recorded%20in%20the%20US%20Food%20and%20Drug%20Administration%20adverse%20event%20reporting%20system%20database&amp;author=M%20Sessa&amp;author=M%20Andersen&amp;volume=35&amp;issue=2&amp;publication_year=2021&amp;pages=215-27&amp;pmid=33609278&amp;doi=10.1007/s40259-021-00469-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref017">
<span class="label">17.</span><cite>Food and Drug Administration [Internet]. Questions and Answers on FDA’s Adverse Event Reporting System (FAERS). [cited 2024 Apr 8]. Available from <a href="https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faers" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faers</a></cite>
</li>
<li id="pone.0330493.ref018">
<span class="label">18.</span><cite>Sakaeda T, Tamon A, Kadoyama K, Okuno Y. Data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci. 2013;10(7):796–803.
</cite> [<a href="https://doi.org/10.7150/ijms.6048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3689877/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23794943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Med%20Sci&amp;title=Data%20mining%20of%20the%20public%20version%20of%20the%20FDA%20Adverse%20Event%20Reporting%20System&amp;author=T%20Sakaeda&amp;author=A%20Tamon&amp;author=K%20Kadoyama&amp;author=Y%20Okuno&amp;volume=10&amp;issue=7&amp;publication_year=2013&amp;pages=796-803&amp;pmid=23794943&amp;doi=10.7150/ijms.6048&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref019">
<span class="label">19.</span><cite>Singh J. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. J Pharmacol Pharmacother. 2015;6(3):185–7. doi: 10.4103/0976-500X.162004

</cite> [<a href="https://doi.org/10.4103/0976-500X.162004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544148/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26312010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharmacol%20Pharmacother&amp;title=International%20conference%20on%20harmonization%20of%20technical%20requirements%20for%20registration%20of%20pharmaceuticals%20for%20human%20use&amp;author=J%20Singh&amp;volume=6&amp;issue=3&amp;publication_year=2015&amp;pages=185-7&amp;pmid=26312010&amp;doi=10.4103/0976-500X.162004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref020">
<span class="label">20.</span><cite>Woods RH. Alopecia signals associated with calcitonin gene-related peptide inhibitors in the treatment or prophylaxis of migraine: a pharmacovigilance study. Pharmacotherapy. 2022;42(10):758–67. doi: 10.1002/phar.2725

</cite> [<a href="https://doi.org/10.1002/phar.2725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35975575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacotherapy&amp;title=Alopecia%20signals%20associated%20with%20calcitonin%20gene-related%20peptide%20inhibitors%20in%20the%20treatment%20or%20prophylaxis%20of%20migraine:%20a%20pharmacovigilance%20study&amp;author=RH%20Woods&amp;volume=42&amp;issue=10&amp;publication_year=2022&amp;pages=758-67&amp;pmid=35975575&amp;doi=10.1002/phar.2725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref021">
<span class="label">21.</span><cite>Zink RC, Huang Q, Zhang L-Y, Bao W-J. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance. Chin J Nat Med. 2013;11(3):314–20. doi: 10.1016/S1875-5364(13)60035-7

</cite> [<a href="https://doi.org/10.1016/S1875-5364(13)60035-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23725848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chin%20J%20Nat%20Med&amp;title=Statistical%20and%20graphical%20approaches%20for%20disproportionality%20analysis%20of%20spontaneously-reported%20adverse%20events%20in%20pharmacovigilance&amp;author=RC%20Zink&amp;author=Q%20Huang&amp;author=L-Y%20Zhang&amp;author=W-J%20Bao&amp;volume=11&amp;issue=3&amp;publication_year=2013&amp;pages=314-20&amp;pmid=23725848&amp;doi=10.1016/S1875-5364(13)60035-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref022">
<span class="label">22.</span><cite>Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483–6. doi: 10.1002/pds.677

</cite> [<a href="https://doi.org/10.1002/pds.677" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11828828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacoepidemiol%20Drug%20Saf&amp;title=Use%20of%20proportional%20reporting%20ratios%20(PRRs)%20for%20signal%20generation%20from%20spontaneous%20adverse%20drug%20reaction%20reports&amp;author=SJ%20Evans&amp;author=PC%20Waller&amp;author=S%20Davis&amp;volume=10&amp;issue=6&amp;publication_year=2001&amp;pages=483-6&amp;pmid=11828828&amp;doi=10.1002/pds.677&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref023">
<span class="label">23.</span><cite>van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(1):3–10. doi: 10.1002/pds.668

</cite> [<a href="https://doi.org/10.1002/pds.668" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11998548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacoepidemiol%20Drug%20Saf&amp;title=A%20comparison%20of%20measures%20of%20disproportionality%20for%20signal%20detection%20in%20spontaneous%20reporting%20systems%20for%20adverse%20drug%20reactions&amp;author=EP%20van%20Puijenbroek&amp;author=A%20Bate&amp;author=HGM%20Leufkens&amp;author=M%20Lindquist&amp;author=R%20Orre&amp;volume=11&amp;issue=1&amp;publication_year=2002&amp;pages=3-10&amp;pmid=11998548&amp;doi=10.1002/pds.668&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref024">
<span class="label">24.</span><cite>Langguth B, Hund V, Busch V, Jürgens TP, Lainez JM, Landgrebe M. Tinnitus and Headache. Biomed Res Int. 2015;2015:797416.
</cite> [<a href="https://doi.org/10.1155/2015/797416" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4637068/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26583133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Res%20Int&amp;title=Tinnitus%20and%20Headache&amp;author=B%20Langguth&amp;author=V%20Hund&amp;author=V%20Busch&amp;author=TP%20J%C3%BCrgens&amp;author=JM%20Lainez&amp;volume=2015&amp;publication_year=2015&amp;pages=797416&amp;pmid=26583133&amp;doi=10.1155/2015/797416&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref025">
<span class="label">25.</span><cite>Goshtasbi K, Abouzari M, Risbud A, Mostaghni N, Muhonen EG, Martin E. Tinnitus and subjective hearing loss are more common in migraine: a cross-sectional NHANES analysis. Otol Neurotol. 2021;42(9):1329–33.
</cite> [<a href="https://doi.org/10.1097/MAO.0000000000003247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8590584/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34238896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Otol%20Neurotol&amp;title=Tinnitus%20and%20subjective%20hearing%20loss%20are%20more%20common%20in%20migraine:%20a%20cross-sectional%20NHANES%20analysis&amp;author=K%20Goshtasbi&amp;author=M%20Abouzari&amp;author=A%20Risbud&amp;author=N%20Mostaghni&amp;author=EG%20Muhonen&amp;volume=42&amp;issue=9&amp;publication_year=2021&amp;pages=1329-33&amp;pmid=34238896&amp;doi=10.1097/MAO.0000000000003247&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref026">
<span class="label">26.</span><cite>Kirchmann M, Thomsen LL, Olesen J. Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology. 2006;66(6):880–6.
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000203647.48422.dd" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16567706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Basilar-type%20migraine:%20clinical,%20epidemiologic,%20and%20genetic%20features&amp;author=M%20Kirchmann&amp;author=LL%20Thomsen&amp;author=J%20Olesen&amp;volume=66&amp;issue=6&amp;publication_year=2006&amp;pages=880-6&amp;pmid=16567706&amp;doi=10.1212/01.wnl.0000203647.48422.dd&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref027">
<span class="label">27.</span><cite>Guichard E, Montagni I, Tzourio C, Kurth T. Association between headaches and tinnitus in young adults: cross-sectional study. Headache. 2016;56(6):987–94. doi: 10.1111/head.12845

</cite> [<a href="https://doi.org/10.1111/head.12845" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27197786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Headache&amp;title=Association%20between%20headaches%20and%20tinnitus%20in%20young%20adults:%20cross-sectional%20study&amp;author=E%20Guichard&amp;author=I%20Montagni&amp;author=C%20Tzourio&amp;author=T%20Kurth&amp;volume=56&amp;issue=6&amp;publication_year=2016&amp;pages=987-94&amp;pmid=27197786&amp;doi=10.1111/head.12845&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref028">
<span class="label">28.</span><cite>Hwang J-H, Tsai S-J, Liu T-C, Chen Y-C, Lai J-T. Association of tinnitus and other cochlear disorders with a history of migraines. JAMA Otolaryngol Head Neck Surg. 2018;144(8):712–7. doi: 10.1001/jamaoto.2018.0939

</cite> [<a href="https://doi.org/10.1001/jamaoto.2018.0939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6143001/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30003226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Otolaryngol%20Head%20Neck%20Surg&amp;title=Association%20of%20tinnitus%20and%20other%20cochlear%20disorders%20with%20a%20history%20of%20migraines&amp;author=J-H%20Hwang&amp;author=S-J%20Tsai&amp;author=T-C%20Liu&amp;author=Y-C%20Chen&amp;author=J-T%20Lai&amp;volume=144&amp;issue=8&amp;publication_year=2018&amp;pages=712-7&amp;pmid=30003226&amp;doi=10.1001/jamaoto.2018.0939&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref029">
<span class="label">29.</span><cite>Brooks KA, Tawk K, Djalilian HR, Hobson CE. Migraine management for the otolaryngologist. Laryngoscope Investig Otolaryngol. 2023;8(4):1080–93.</cite> [<a href="https://doi.org/10.1002/lio2.1109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10446291/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37621262/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Laryngoscope%20Investig%20Otolaryngol&amp;title=Migraine%20management%20for%20the%20otolaryngologist&amp;author=KA%20Brooks&amp;author=K%20Tawk&amp;author=HR%20Djalilian&amp;author=CE%20Hobson&amp;volume=8&amp;issue=4&amp;publication_year=2023&amp;pages=1080-93&amp;pmid=37621262&amp;doi=10.1002/lio2.1109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref030">
<span class="label">30.</span><cite>Ong JJY, De Felice M. Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics. 2018;15(2):274–90. doi: 10.1007/s13311-017-0592-1

</cite> [<a href="https://doi.org/10.1007/s13311-017-0592-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5935632/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29235068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurotherapeutics&amp;title=Migraine%20treatment:%20current%20acute%20medications%20and%20their%20potential%20mechanisms%20of%20action&amp;author=JJY%20Ong&amp;author=M%20De%20Felice&amp;volume=15&amp;issue=2&amp;publication_year=2018&amp;pages=274-90&amp;pmid=29235068&amp;doi=10.1007/s13311-017-0592-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref031">
<span class="label">31.</span><cite>Schwedt TJ, Garza M.
Acute treatment of migraine in adults. In: Swanson JW, Goddeau RP, editors. UptoDate. [cited 2024 Apr 8]. Available from: <a href="https://www.uptodate.com/contents/acute-treatment-of-migraine-in-adults#H1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.uptodate.com/contents/acute-treatment-of-migraine-in-adults#H1</a></cite> [<a href="https://scholar.google.com/scholar_lookup?title=UptoDate&amp;author=TJ%20Schwedt&amp;author=M.%20Garza&amp;author=JW%20Swanson&amp;author=RP%20Goddeau&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref032">
<span class="label">32.</span><cite>Thorlund K, Mills EJ, Wu P, Ramos E, Chatterjee A, Druyts E, et al. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis. Cephalalgia. 2014;34(4):258–67. doi: 10.1177/0333102413508661

</cite> [<a href="https://doi.org/10.1177/0333102413508661" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24108308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cephalalgia&amp;title=Comparative%20efficacy%20of%20triptans%20for%20the%20abortive%20treatment%20of%20migraine:%20a%20multiple%20treatment%20comparison%20meta-analysis&amp;author=K%20Thorlund&amp;author=EJ%20Mills&amp;author=P%20Wu&amp;author=E%20Ramos&amp;author=A%20Chatterjee&amp;volume=34&amp;issue=4&amp;publication_year=2014&amp;pages=258-67&amp;pmid=24108308&amp;doi=10.1177/0333102413508661&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref033">
<span class="label">33.</span><cite>Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358(9294):1668–75.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(01)06711-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11728541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Oral%20triptans%20(serotonin%205-HT(1B/1D)%20agonists)%20in%20acute%20migraine%20treatment:%20a%20meta-analysis%20of%2053%20trials&amp;author=MD%20Ferrari&amp;author=KI%20Roon&amp;author=RB%20Lipton&amp;author=PJ%20Goadsby&amp;volume=358&amp;issue=9294&amp;publication_year=2001&amp;pages=1668-75&amp;pmid=11728541&amp;doi=10.1016/S0140-6736(01)06711-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref034">
<span class="label">34.</span><cite>Mostyn RH. Tinnitus and propranolol. Br Med J. 1969;2(5659):766. doi: 10.1136/bmj.2.5659.766

</cite> [<a href="https://doi.org/10.1136/bmj.2.5659.766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1983574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/5786777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20Med%20J&amp;title=Tinnitus%20and%20propranolol&amp;author=RH%20Mostyn&amp;volume=2&amp;issue=5659&amp;publication_year=1969&amp;pages=766&amp;pmid=5786777&amp;doi=10.1136/bmj.2.5659.766&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330493.ref035">
<span class="label">35.</span><cite>Albertino S, de Assunção ARM, Souza JA. Pulsatile tinnitus: treatment with clonazepam and propranolol. Braz J Otorhinolaryngol. 2005;71(1):111–3. doi: 10.1016/s1808-8694(15)31297-0

</cite> [<a href="https://doi.org/10.1016/s1808-8694(15)31297-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9443577/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16446904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Braz%20J%20Otorhinolaryngol&amp;title=Pulsatile%20tinnitus:%20treatment%20with%20clonazepam%20and%20propranolol&amp;author=S%20Albertino&amp;author=ARM%20de%20Assun%C3%A7%C3%A3o&amp;author=JA%20Souza&amp;volume=71&amp;issue=1&amp;publication_year=2005&amp;pages=111-3&amp;pmid=16446904&amp;doi=10.1016/s1808-8694(15)31297-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Fig. Inter-class analysis of migraine drugs without restriction for indication.</span><p>Proportional reporting ratios (PRR) and reporting odds ratios (ROR), along with their respective 95% confidence intervals, contrast tinnitus cases associated with each migraine drug class against (a) CGRP inhibitors and (b) serotonin receptor agonists. CGRP stands for calcitonin gene-related peptide.</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367135/bin/pone.0330493.s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0330493.s001.pdf</a><sup> (313.7KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data analyzed in this study are publicly available from the US Food and Drug Administration’s Adverse Event Reporting System (FAERS). The full FAERS dataset can be accessed via the FDA’s official website: <a href="https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html</a>
</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0330493"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0330493.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (672.5 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12367135/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12367135/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367135%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367135/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12367135/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12367135/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40833961/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12367135/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40833961/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12367135/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12367135/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="nRQV8rsKqyQliSKleKaJ0XtKjzYWMPnqj4TvpZAZ9Xh14lUrBlMQUUSODy4T65oq">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
